- Dunnigan familial partial lipodystrophy
-
Dunnigan familial partial lipodystrophy Classification and external resources OMIM 151660 Dunnigan-type familial partial lipodystrophy, abbreviated as (FPLD), is a rare monogenic form of insulin resistance characterized by loss of subcutaneous fat from the extremities, trunk, and gluteal region. FPLD recapitulates the main metabolic attributes of the insulin resistance syndrome, including central obesity, hyperinsulinemia, glucose intolerance and diabetes[1] usually type 2,[2] dyslipidemia, hypertension,[1] and early endpoints of atherosclerosis.[2] It can also result in hepatic steatosis.[3] FPLD results from mutations in LMNA gene, which is the gene that encodes nuclear lamins A and C.[1]
See also
- Familial partial lipodystrophy
References
- ^ a b c Hegele RA (December 2000). "Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome". Mol. Genet. Metab. 71 (4): 539–44. doi:10.1006/mgme.2000.3092. PMID 11136544. http://linkinghub.elsevier.com/retrieve/pii/S1096-7192(00)93092-0.
- ^ a b Hegele RA (September 2000). "Insulin resistance in human partial lipodystrophy". Curr Atheroscler Rep 2 (5): 397–404. doi:10.1007/s11883-000-0078-0. PMID 11122771.
- ^ Lüdtke A, Genschel J, Brabant G, et al. (October 2005). "Hepatic steatosis in Dunnigan-type familial partial lipodystrophy". Am. J. Gastroenterol. 100 (10): 2218–24. doi:10.1111/j.1572-0241.2005.00234.x. PMID 16181372.
Categories:- Genetic disorders
- Conditions of the subcutaneous fat
- Medicine stubs
Wikimedia Foundation. 2010.